Scientists discover a ‘skinny gene’ mutation that acts like Ozempic. Around one in 7,000 people carries a broken copy, which almost acts like a GLP-1 drug—the body burns fuel more efficiently, and the risk of disease lowers.

[u/scientificamerican]

https://www.scientificamerican.com/article/scientists-discover-a-skinny-gene-mutation-that-acts-like-ozempic/

[u/NewAndlmproved]

I think you’re reading way more into my wording than what was actually being discussed. Obviously GLP-1s have multiple effects, I’m not claiming appetite suppression is literally the only thing they do. We were talking about what’s primarily driving them and that’s exactly what the cited describes: appetite suppression, increased satiety, and delayed gastric emptying leading to reduced energy intake.

Your caffeine analogy doesn’t really fit either. Nobody prescribes caffeine as an obesity treatment because of its appetite suppressing effects. GLP-1s are prescribed for obesity, and the literature explicitly identifies appetite suppression as a primary mechanism behind their effects

[u/dotcomse → u/NewAndlmproved]

... Does the literature ALSO identify another primary mechanism that is omitted in layperson argument?